Creating Vaccines to Address Global Health Challenges
We are developing low cost of goods vaccines using our patented platform to improve vaccines and vaccine access
Follow us on social media for company updates
Innovative Vaccines
Efficient Plant Expression
A Global Approach
Featured News Stories and Company Achievements
On March 24th, we received our first STTR grant from the National Institutes of Health - National Cancer Institute! This award will help us continue the research on our lead product - a low-cost, plant-expressed HPV vaccine. We're looking forward to working with our sub-award PI, Dr. Hugh Mason, at Arizona State University.
VaxSyna, INC presented a rapid-fire pitch at the AZAdvances Life Sciences Innovation Showcase and won 3rd place in the 'Seed Stage' category.
VaxSyna, LLC was named a winner of the Innovate Children's Health Challenge (ICHC), an innovation contest run by the Center for Advancing Innovation (CAI) and funded by the Resonance Philanthropies of the Silicon Valley Community Foundation.
The VaxSyna Team
Mary Pardhe, PhD
Co-founder and Inventor
- Co-inventor of the Universal RIC Vaccine Platform
- Co-first author of a RIC/VLP synergy research paper
- Science and business experience
Kaitlyn Morse, PhD
Co-founder
- Created vaccine against anaplasmosis
- Co-inventor of laser adjuvant
- Founder of a Biotechnology non-profit
Joseph Hunter, MS
Co-founder
- Co-founder and CSO of other start-up companies.
- Spearheading current HPV research
- NSF Fellow
Hugh Mason, PhD
Inventor and Scientific Advisor
- Associate Professor at ASU
- Pioneer of plant made vaccines
- Inventor of the RIC platform
Kate Tulenko, MD, MPH
Advisor
- Physician and health workforce expert
- Board Chair of Corvus Health
- Served as Director of USAID’s CapacityPlus project
Travis Whitfill, PhD MPH
Advisor
- Associate research scientist at Yale
- Founder and CEO of Azitra
- Healthcare solutions investor
Olenka Cullinan, MS
Advisor
- CEO #iStartFirst
- Business and Coach and Corporate Trainer